Companies / CN-Bio
CN-Bio
United Kingdom
CN Bio enables the generation of human-specific efficacy, ADME and safety data with pioneering PhysioMimix solutions
CN-Bio, based in United Kingdom, has 1 investor on file, among them GrayBella Capital. Its site was last checked 20 Nov 2026: site answers.
Investors
1 investor on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital |
More from GrayBella Capital
4 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (75%), Fintech (25%).
See GrayBella Capital's full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get CN-Bio and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when GrayBella Capital adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/cn-bio.com/investors
# also
GET /v1/companies/cn-bio.com
GET /v1/companies/cn-bio.com/news